Abstract 040: Hemorrhagic Conversion Patterns After Transition of Stroke Thrombolysis from Alteplase to Tenecteplase; Real‐World Experience
Introduction Importance:Tenecteplase (TNK) use is more prevalent as the thrombolytic drug of choice for acute ischemic stroke (AIS), given its ease of use with results from randomized trials showing non‐ inferiority and comparable safety to Alteplase (tPA). However, there is conflicting data in term...
Main Authors: | Mohamad Ezzeldin, Courtney Hill, Eryn Percenti, Ali Kerro, Adam Delora, Juan Santos, Hamza Saei, Lisa Greco, Rime Ezzeldin, Mohammad Elghanem, Yazan Alderazi, Yana Kim, Cathleen Poitevint, Osman Mir |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-11-01
|
Series: | Stroke: Vascular and Interventional Neurology |
Online Access: | https://www.ahajournals.org/doi/10.1161/SVIN.03.suppl_2.040 |
Similar Items
-
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
by: Annie Zhu, et al.
Published: (2022-08-01) -
Feasibility of switching from alteplase to tenecteplase for stroke thrombolysis – A retrospective cohort analysis
by: Vilhelm Sjögren, et al.
Published: (2023-06-01) -
Replacing Alteplase with Tenecteplase: Is the Time Ripe?
by: Nishita Singh, et al.
Published: (2023-01-01) -
Tenecteplase and alteplase for thrombolysis of acute ischemic stroke within 4.5 hours: An efficacy and safety study
by: Nikita Dhar, et al.
Published: (2022-01-01) -
Switching from Alteplase to Tenecteplase: Time to AcT?
by: Eric D. Goldstein, et al.
Published: (2022-09-01)